Navigation Links
Shire Provides Update on ProAmatine® (midodrine HCl)
Date:9/22/2011

orward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, the Company's results could be materially adversely affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of research, development, approval, reimbursement, manufacturing and commercialization of the Company's Specialty Pharmaceutical and Human Genetic Therapies products, as well as the ability to secure and integrate new products for commercialization and/or development; government regulation of the Company's products; the Company's ability to manufacture its products in sufficient quantities to meet demand; the impact of competitive therapies on the Company's products; the Company's ability to register, maintain and enforce patents and other intellectual property rights relating to its products; the Company's ability to obtain and maintain government and other third-party reimbursement for its products; and other risks and uncertainties detailed from time to time in the Company's filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
2. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
3. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
4. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
5. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
6. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
7. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
8. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
9. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
10. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
11. Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 6, 2015  Mirati Therapeutics, Inc. ("Mirati") (NASDAQ: ... quarter ended March 31, 2015 and provided an update ... continue to make progress across our targeted oncology clinical ... president and CEO, Mirati. "We look forward to providing ... of Clinical Oncology meeting at the end of the ...
(Date:5/6/2015)... May 6, 2015 Lannett Company, Inc. (NYSE: ... fiscal 2015 third quarter ended March 31, 2015.  ... sales rose 24% to $99.4 million from $80.0 million ... to $75.6 million, or 76% of net sales, from ... development (R&D) expenses decreased to $9.2 million from $10.6 ...
(Date:5/6/2015)... , May 6, 2015 CVS Health (NYSE: CVS ... Baltimore locations that sustained heavy fire damage during ... in Baltimore over the past week or ... is ahead," said CVS Health President and CEO Larry Merlo ... path to better health. There is no better way that we ...
Breaking Medicine Technology:Mirati Therapeutics Reports First Quarter 2015 Financial Results and Provides Business Update 2Mirati Therapeutics Reports First Quarter 2015 Financial Results and Provides Business Update 3Mirati Therapeutics Reports First Quarter 2015 Financial Results and Provides Business Update 4Mirati Therapeutics Reports First Quarter 2015 Financial Results and Provides Business Update 5Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 2Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 3Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 4Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 5Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 6Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 7Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 8CVS Health Announces it Will Rebuild Baltimore CVS/pharmacy Locations 2
... 11, 2011 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: ... medical dressings, medical disposables and non-woven fabric made from 100% natural ... second quarter ended March 31, 2011. Second Quarter ... Revenue increased by 27% over Q2 FY 2010 to ...
... 11, 2011 Reportlinker.com announces that ... available in its catalogue: ... – Generics Market Overview: Patent cliff ... despite tougher market conditions ...
Cached Medicine Technology:Winner Medical Reports Second Quarter Fiscal 2011 Results 2Winner Medical Reports Second Quarter Fiscal 2011 Results 3Winner Medical Reports Second Quarter Fiscal 2011 Results 4Winner Medical Reports Second Quarter Fiscal 2011 Results 5Winner Medical Reports Second Quarter Fiscal 2011 Results 6Winner Medical Reports Second Quarter Fiscal 2011 Results 7Winner Medical Reports Second Quarter Fiscal 2011 Results 8Winner Medical Reports Second Quarter Fiscal 2011 Results 9Winner Medical Reports Second Quarter Fiscal 2011 Results 10Winner Medical Reports Second Quarter Fiscal 2011 Results 11Winner Medical Reports Second Quarter Fiscal 2011 Results 12Winner Medical Reports Second Quarter Fiscal 2011 Results 13Winner Medical Reports Second Quarter Fiscal 2011 Results 14Winner Medical Reports Second Quarter Fiscal 2011 Results 15Winner Medical Reports Second Quarter Fiscal 2011 Results 16Winner Medical Reports Second Quarter Fiscal 2011 Results 17Reportlinker Adds Pharmaceutical Key Trends 2011 - Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions 2Reportlinker Adds Pharmaceutical Key Trends 2011 - Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions 3Reportlinker Adds Pharmaceutical Key Trends 2011 - Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions 4Reportlinker Adds Pharmaceutical Key Trends 2011 - Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions 5
(Date:5/6/2015)... Imprivata ® (NYSE: IMPR), the ... Ting will lead a discussion about the Internet of ... user authentication challenges, during Citrix Synergy (May ... on the benefits of creating a network of IP-connected ... patients can share information. It will also emphasize the ...
(Date:5/6/2015)... quality built chicken coop condo with a wheel kit is a ... on a pasture. By installing a wheel kit on a ... tractor that stands up to being moved around the pasture every ... to flex to uneven ground without losing its shape. It ... it will help provide the chickens with fresh foraging plots each ...
(Date:5/6/2015)... May 05, 2014 (PRWEB) May 06, 2015 ... Lock accepted, on behalf of MEBC, an Alliance ... from JDA Software during FOCUS 2015, JDA’s annual ... across the manufacturing, retail and wholesale distribution sectors. ... that their clients are receiving services that advance ...
(Date:5/6/2015)... Vancouver, BC (PRWEB) May 06, 2015 ... colon hydrotherapy supplier, is excited to announce a ... will help reduce the industry’s carbon footprint while ... These kits feature Eco-Flex™, the world’s ... “This is a game-changer for hydrotherapists,” claims the ...
(Date:5/6/2015)... PA (PRWEB) May 06, 2015 TMG ... solutions to the Medicare Advantage, Medicare Part D and ... the Continuity and Resilience Team category at the BCI ... Continuity Institute to recognize the outstanding contribution of business ... the North America Region, including the USA and Canada. ...
Breaking Medicine News(10 mins):Health News:Imprivata to Lead Discussion about Patient and Provider Authentication Challenges and the Internet of Things in Healthcare during Citrix Synergy 2Health News:Chicken Coop Condo Launches the Chicken Tractor 2Health News:MEBC Receives Award for Consulting Excellence in Retail 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3Health News:TMG Health Recognized by the Business Continuity Institute 2Health News:TMG Health Recognized by the Business Continuity Institute 3
... carotene, either individually or in combination, do not appear ... among women at high risk for heart disease, according ... Archives of Internal Medicine, one of the JAMA/Archives journals. ... oxygenmay contribute to the development of cardiovascular disease, according ...
... may produce beneficial changes in the brains and immune ... article posted online today that will appear in the ... of the JAMA/Archives journals. , In patients with multiple ... that protect nerve cells in the brain and spinal ...
... be associated with a decreasing peripheral field of vision ... remains low overall, according to a report in the ... JAMA/Archives journals. , Prevention of further visual field deterioration ... as background information in the article. Previous studies reported ...
... 2007, Paying out certain types of government aid in a ... and often fatal drug binges, according to a new study ... that links the monthly arrival of disability checks with a ... by researchers at the University of California, Santa Cruz and ...
... structural damage to DNA, players in two important pathways ... scientists at The University of Texas M. D. Anderson ... , This connection between a signaling pathway crucial to ... remodeling "opens an entirely new category of targets for ...
... 2007 New research from scientists at UT Southwestern ... underscores the importance of preventing recurring acid reflux while ... can turn potentially cancerous. , In research published in ... reflux disease, particularly those with a complication of acid ...
Cached Medicine News:Health News:Antioxidants show no clear benefit against cardiovascular events, death in high-risk women 2Health News:DNA vaccine against multiple sclerosis appears safe, potentially beneficial 2Health News:Fluctuating eye pressure associated with visual field deterioration in glaucoma patients 2Health News:Disability payments may spur drug abuse 2Health News:Chromatin remodeling complex connected to DNA damage control 2Health News:Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer 2Health News:Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer 3
Height-Adjustable Mobile X-ray Barrier lets you get close to your patient during special procedures like cardiac cath. 24"H x 36"W viewing panel shields the upper body of one or two people and swivel...
Ball-and-socket center mount can rotate 360, allowing them to be turned hoirzontally, vertically, or at any angle. Very versatile! Available with or without torso placement contour cutout and in thre...
Wrap-Around, Full Protection Apron with BACK SUPPORT...
All Day Comfort for the Lower Body...
Medicine Products: